Deciphera Pharmaceuticals...

NASDAQ: DCPH · Real-Time Price · USD
25.59
0.02 (0.08%)
At close: Jun 10, 2024, 10:00 PM

Deciphera Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
83.51M 64.74M 87.06M
Short-Term Investments
222.71M 259.75M 198.57M
Long-Term Investments
46.7M 14.55M 41.95M
Other Long-Term Assets
8.28M 3.28M 3.11M
Receivables
31.95M 22.43M 20.59M
Inventory
21.21M 20.56M 14.13M
Other Current Assets
21.72M 25.48M 18.66M
Total Current Assets
381.1M 392.96M 339.01M
Property-Plant & Equipment
37.49M 43.25M 45.41M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
92.47M 61.08M 90.47M
Total Assets
473.57M 454.04M 429.48M
Account Payables
26.48M 18.61M 13.13M
Deferred Revenue
68.35M n/a 79.7M
Short-Term Debt
3.5M 3.23M 2.87M
Other Current Liabilities
1.95M 64.62M 1.07M
Total Current Liabilities
100.28M 86.47M 96.77M
Long-Term Debt
22.38M 25.88M 27.99M
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
22.38M 25.88M 27.99M
Total Liabilities
122.65M 112.35M 124.76M
Total Debt
25.88M 29.11M 30.86M
Common Stock
805K 676K 585K
Retained Earnings
-1.43B -1.23B -1.05B
Comprehensive Income
577K -983K 51K
Shareholders Equity
350.92M 341.69M 304.72M
Total Investments
269.41M 274.3M 240.52M